Related Experiment Video
Updated: May 20, 2025

07:25
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.4K
Applying mobility prediction models to real-world patients with major amputations
Leigh Ann O'Banion1, Caroline Runco1, Carolina Aparicio1
1Division of Vascular Surgery, University of California San Francisco Fresno, Fresno, CA.
Journal of Vascular Surgery
|March 23, 2025
Summary
Published mobility prediction models (PMs) overestimated patient outcomes in a disadvantaged population. Caution is advised when applying these models to diverse patient groups due to differing demographics and comorbidities.
Area of Science:
- Rehabilitation Medicine
- Prosthetics and Orthotics
- Health Services Research
Background:
- Mobility prediction models (PMs) are widely used for patient counseling post-major amputation (MA).
- Existing PMs require validation in real-world, socioeconomically diverse populations.
- This study evaluates PM performance in a disadvantaged population with peripheral arterial disease-related MA.
Purpose of the Study:
- To assess the accuracy of established mobility prediction models in a socioeconomically disadvantaged patient cohort undergoing major amputation.
- To compare predicted versus actual mobility outcomes at one year post-amputation.
Main Methods:
- Retrospective review of 126 patients with MA due to peripheral arterial disease (2016-2022).
- Exclusion of nonambulatory patients pre-MA or with contralateral MA.
- Evaluation of three PMs: AmpPredict, Amputee Single Item Mobility Measure, and a Vascular Quality Initiative (VQI) model.
Main Results:
- The cohort (60% non-White, Area Deprivation Index 9/10) differed significantly from PM derivation cohorts.
- Actual one-year mobility was 43%; published models showed poor predictive accuracy.
- AmpPredict and VQI models overestimated mobility, with significant discrepancies between predicted and actual rates.
Conclusions:
- Existing mobility prediction models significantly overestimate functional mobility in socioeconomically disadvantaged populations.
- Demographic and comorbidity differences between patient cohorts impact model performance.
- Clinical application of PMs requires careful consideration of patient population characteristics relative to model derivation data.

